Literature DB >> 8870816

An immunological and genetic study of patients with gestational diabetes mellitus.

A Lapolla1, C Betterle, M Sanzari, R Zanchetta, E Pfeifer, A Businaro, U Fagiolo, M Plebani, S Marini, E Photiou, D Fedele.   

Abstract

The aim of the study was to evaluate the frequency of islet cell (ICA) and insulin (IAA) antibodies and of HLA antigen typing in a group of subjects diagnosed with gestational diabetes mellitus (GDM) in a screening-diagnostic program during pregnancy. ICA, complement-fixing (CF) ICA and other autoantibodies, absolute number and percentage of lymphocyte subpopulations, and HLA antigens were evaluated in 68 women with GDM and compared with those of matched controls. ICA were found in 2 (2.9%) and IAA in 1 (1.5%). Both ICA-positive women had CF-ICA; one of them was receiving insulin therapy. while the other was on a special diet. No correlations were found between ICA and IAA, nor between IAA and insulin treatment. As far as lymphocyte subsets were concerned, we found a significant increase in the absolute number of total and activated (CD3+HLA-DR+) T lymphocytes and a significant increase in the absolute number and percentage of suppressor/cytotoxic T lymphocytes (CD8) and NK lymphocytes (CD57) in GDM patients compared with normal pregnant controls. Concerning frequency for HLA A, B, C, DR antigens in the GDM population, only Cw7 was found to be significantly increased and A10 significantly decreased in comparison with controls. Our study suggests that GDM is a heterogeneous disorder in which few patients present with the immunologic and genetic markers of type 1 diabetes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8870816     DOI: 10.1007/bf00569424

Source DB:  PubMed          Journal:  Acta Diabetol        ISSN: 0940-5429            Impact factor:   4.280


  32 in total

1.  Improved B cell typing for HLA-DR using nylon wool column enriched B lymphocyte preparations.

Authors:  R Lowry; J Goguen; C B Carpenter; T B Strom; M R Garovoy
Journal:  Tissue Antigens       Date:  1979-10

2.  Islet cell antibodies in gestational diabetics.

Authors:  F Ginsberg-Fellner; E M Mark; C Nechemias; R U Hausknecht; P Rubinstein; M J Dobersen; A L Notkins
Journal:  Lancet       Date:  1980-08-16       Impact factor: 79.321

3.  Life-table analysis of progression to diabetes of anti-insulin autoantibody-positive relatives of individuals with type I diabetes.

Authors:  A G Ziegler; R Ziegler; P Vardi; R A Jackson; J S Soeldner; G S Eisenbarth
Journal:  Diabetes       Date:  1989-10       Impact factor: 9.461

4.  Immunology in diabetic pregnancy: activated T cells in diabetic mothers and neonates.

Authors:  U Di Mario; F Dotta; P Gargiulo; J Sutherland; D Andreani; K Guy; A Pachi; F Fallucca
Journal:  Diabetologia       Date:  1987-02       Impact factor: 10.122

Review 5.  Etiology and pathophysiology of gestational diabetes mellitus.

Authors:  C Kühl; P J Hornnes; O Andersen
Journal:  Diabetes       Date:  1985-06       Impact factor: 9.461

6.  Gestational diabetes mellitus. Heterogeneity of maternal age, weight, insulin secretion, HLA antigens, and islet cell antibodies and the impact of maternal metabolism on pancreatic B-cell and somatic development in the offspring.

Authors:  N Freinkel; B E Metzger; R L Phelps; S L Dooley; E S Ogata; R M Radvany; A Belton
Journal:  Diabetes       Date:  1985-06       Impact factor: 9.461

7.  Long-range implications for the mother. The Aberdeen experience.

Authors:  J M Stowers; H W Sutherland; D F Kerridge
Journal:  Diabetes       Date:  1985-06       Impact factor: 9.461

8.  Metabolic alterations in adulthood after intrauterine development in mothers with mild diabetes.

Authors:  F A Van Assche; L Aerts; K Holemans
Journal:  Diabetes       Date:  1991-12       Impact factor: 9.461

9.  Diabetes mellitus after GDM.

Authors:  J B O'Sullivan
Journal:  Diabetes       Date:  1991-12       Impact factor: 9.461

10.  Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group.

Authors: 
Journal:  Diabetes       Date:  1979-12       Impact factor: 9.461

View more
  2 in total

1.  Glycosylation failure extends to glycoproteins in gestational diabetes mellitus: evidence from reduced α2-6 sialylation and impaired immunomodulatory activities of pregnancy-related glycodelin-A.

Authors:  Cheuk-Lun Lee; Philip C N Chiu; Poh-Choo Pang; Ivan K Chu; Kai-Fai Lee; Riitta Koistinen; Hannu Koistinen; Markku Seppälä; Howard R Morris; Bérangère Tissot; Maria Panico; Anne Dell; William S B Yeung
Journal:  Diabetes       Date:  2011-02-07       Impact factor: 9.461

2.  The relationships between HLA class II alleles and antigens with gestational diabetes mellitus: A meta-analysis.

Authors:  Cong-Cong Guo; Yi-Mei Jin; Kenneth Ka Ho Lee; Guang Yang; Chun-Xia Jing; Xuesong Yang
Journal:  Sci Rep       Date:  2016-10-10       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.